AI Clinical Trial Automation Specialist
An AI Clinical Trial Automation Specialist designs, deploys, and maintains intelligent systems that accelerate every phase of clin…
Skill Guide
The practice of structuring, mapping, and implementing the CDISC ODM (Operational Data Model), USDM (Unified Study Data Model), and FHIR (Fast Healthcare Interoperability Resources) standards to ensure clinical trial data is interoperable, regulatory-compliant, and machine-readable for submission and analysis.
Scenario
A small Phase I study for a new drug needs its protocol defined in a digital, machine-readable format to configure the EDC system.
Scenario
A CRO is tasked with receiving a full study dataset from an EDC vendor in ODM format and transforming it into submission-ready SDTM domains for the FDA.
Scenario
A hospital network wants to conduct a pragmatic trial using real-world data (RWD) from their Epic EHR, while a pharma sponsor requires the data in CDISC format for their regulatory submission.
SAS remains the industry standard for final SDTM/ADaM creation and validation. Python/R are used for intermediate data wrangling and automation. COSV is critical for validating datasets against CDISC standards. Knowledge of major EDC systems is required to extract and understand source data.
ODM/USDM are the backbone for study metadata. CDASH defines CRF design, SDTM/ADaM are for analysis/submission. FHIR is for interoperability with health systems. Controlled Terminology ensures coded values are consistent and regulatory-compliant.
CDISC 360i provides a model-driven approach for automating dataset creation. Governance ensures standards are applied consistently across a portfolio. Understanding submission strategy (e.g., FDA Technical Rejection Criteria) dictates how you implement and validate your data.
Answer Strategy
Demonstrate a systematic, tool-driven approach. First, acknowledge that schema validity ≠ semantic validity. Explain using a tool like COSV to run the SDTM validation on the derived dataset to pinpoint the exact ODM items and non-compliant values. Then, describe creating a Data Clarification Form (DCF) to the vendor, specifying the required Controlled Terminology and the ODM ItemDef OIDs to update. Emphasize the need to trace the fix back to the source ODM to prevent recurrence.
Answer Strategy
Test strategic risk assessment. Sample answer: 'First, Data Fidelity and Mapping Risk: FHIR data is clinical care-centric, not trial-centric. Key protocol-specific data points may be missing or in non-standard formats, requiring complex, validated mapping logic to CDISC. Second, Regulatory and Privacy Risk: Ensuring data provenance and audit trails across two distinct systems (FHIR server and EDC) to meet 21 CFR Part 11 is non-trivial. HIPAA/GDPR compliance must be baked into the API contract. Third, Operational Continuity Risk: FHIR endpoints are not designed for the batch, periodic data extractions typical of trials. We need a robust strategy for handling API downtime, version changes, and incremental data loading.'
1 career found
Try a different search term.